ArticleInternational journal of rheumatology2011

Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway.

Jeroen P Jansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.